Clinical trial Recruiting at 1 site Observational Ages 65 and up

How ciprofol behaves and affects older adults having limb surgery under general anesthesia

Official title: Population Pharmacokinetic/Pharmacodynamic Modeling of Ciprofol in Elderly Patients Undergoing Orthopedic Limb Surgery

Run by Shanghai Geriatric Medical Center · NCT07301242 · Data updated 2026-11-12

This study tests whether ciprofol provides safe and effective anesthesia for older adults having elective limb surgery by measuring drug levels and clinical responses.

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment50 (estimated)
SponsorShanghai Geriatric Medical Center
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedOctober 28, 2025
Main results expectedNovember 2026
Study endsDecember 2026
Registry record updatedDecember 24, 2025
Trial IDNCT07301242 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 65 or older with BMI 18–30 kg/m², ASA physical status I–III, scheduled for elective orthopedic limb surgery lasting more than 30 minutes, and able to give informed consent.

Probably not a fit

Patients younger than 65, those not receiving ciprofol, emergency surgery cases, or people with significant preoperative cognitive impairment or contraindications to ciprofol are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective observational project enrolling patients aged 65 and older who receive ciprofol as part of routine general anesthesia for elective orthopedic limb surgery. Participants will provide timed blood samples during and after surgery while researchers record vital signs, anesthesia dosing, recovery scores (such as the Aldrete score), and signs of postoperative delirium. Collected data will be used to build and validate a population pharmacokinetic/pharmacodynamic (PK/PD) model tailored to elderly orthopedic patients. The validated model aims to support target-controlled infusion (TCI) systems for more individualized intraoperative dosing.

Why it matters

Potential benefit: If successful, the generated PK/PD model could help clinicians use TCI to tailor ciprofol dosing in elderly patients and reduce risks of over- or under-dosing.

How similar studies have gone: Ciprofol has shown promising safety and efficacy in earlier trials mostly involving younger or healthier populations, but PK/PD models for elderly orthopedic patients remain limited, so applying these methods in this group is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥65 years;
* BMI: 18-30 kg/m²;
* ASA physical status classification I-III;
* Scheduled for elective orthopedic limb surgery under general anesthesia;
* Expected duration of surgery \>30 minutes;
* Willing to participate and able to provide written informed consent.

Exclusion Criteria:

* Known allergy to ciprofol or related medications, or any contraindication to their use;
* Preoperative cognitive impairment;
* History of severe cerebrovascular disease or related complications;
* History of neuromuscular system diseases or psychiatric disorders;
* History of sedative medication use;
* History of alcohol abuse or substance use disorder;
* Bradycardia (heart rate \<60 beats per minute);
* Hypotension (mean arterial pressure \<55 mmHg);
* QT interval prolongation;
* Uncooperative or unable to communicate effectively.

Where it's running

  • Shanghai Geriatric Medical Center
    Shanghai, China
    Recruiting

Study contacts

  • Principal investigator: Xue Zhang — Shanghai Geriatric Medical Center
  • Study coordinator: Xue Zhang
  • Email: zx02190554@126.com
  • Phone: 02164175590

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.